Company intelligence / Profile preview

Senescence Life Sciences

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Senescence Life Sciences was a biotechnology company dedicated to the development of advanced nutraceuticals designed to support brain health and mitigate age-related cognitive decline. Founded by neuroscientists, the company focused on the role of mitochondrial health and oxidative stress in the aging process. Their product line, including the flagship supplement REVIVE, aimed to provide neuroprotective benefits and enhance cognitive performance through evidence-based formulations. While initially gaining traction in the Singapore and Canadian markets, the company's primary focus was bridging the gap between pharmaceutical-grade research and consumer health products.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on Senescence Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senescence Life Sciences.

Explore the full profile